Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Completed · Phase 1/Phase 2

Conditions studied: Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy and kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation or bone marrow transplantation in treating patients who have relapsed or recurrent germ cell cancer.

Key facts

Study ID

NCT00002508

Run by

Temple University

Starts

1990-11-01

Expected to finish

2001-09-01

Last updated by the study team

2010-10-01

Who can join

Age: 15 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Temple University Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.